Mesa Laboratories (MLAB) Debt/Equity Ratio: History & Chart

Mesa Laboratories, Inc.(MLAB)

Medical - Specialties · Lakewood, CO

$137.18-5.05 (-3.55%)

Delayed quote: Oct 6, 2026, 12:35 PM EDT

About Mesa Laboratories, Inc.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Lakewood, CO

717 employees

www.mesalabs.com

Healthcare / Medical - Specialties

Sector: Healthcare
Industry: Medical - Specialties
CEO: Siddhartha C. Kadia

View full financials

MLAB Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

0.54

DEBT TO EQUITY RATIO AVG TTM

0.91

DEBT TO EQUITY RATIO AVG 3Y

1.00

DEBT TO EQUITY RATIO AVG 5Y

0.81

DEBT TO EQUITY RATIO AVG 10Y

0.48

DEBT TO EQUITY RATIO AVG 15Y

0.40

DEBT TO EQUITY RATIO AVG 20Y

0.34

CURRENT VS TTM AVG

-41.02%

CURRENT VS 3Y AVG

-46.05%

CURRENT VS 5Y AVG

-33.62%

CURRENT VS 10Y AVG

+11.94%

CURRENT VS 15Y AVG

+32.89%

CURRENT VS 20Y AVG

+60.23%

SECTOR MEDIAN · HEALTHCARE

0.12

median of 684 covered companies

CURRENT VS SECTOR MEDIAN

+347.47%

vs the sector median at left

NAME	MARKET CAP	DEBT TO EQUITY RATIO	TTM	3Y	5Y
Mesa Laboratories, Inc. (MLAB)	$767.66M	0.54	0.91	1.00	0.81
Attovia Therapeutics, Inc. (ATTO)vs ›	$774.97M	0.04	0.01	0.01	0.01
Lexicon Pharmaceuticals, Inc. (LXRX)vs ›	$775.17M	0.34	0.66	0.73	0.51
Design Therapeutics, Inc. (DSGN)vs ›	$758.23M	0.01	0.01	0.01	0.01
Sana Biotechnology, Inc. (SANA)vs ›	$782.00M	0.48	0.43	0.36	0.32
Apnimed, Inc. (APMD)vs ›	$788.50M	N/A	N/A	N/A	N/A
Gyre Therapeutics, Inc. (GYRE)vs ›	$793.58M	0.03	0.02	0.02	0.03
Geron Corporation (GERN)vs ›	$795.49M	0.56	0.77	0.65	0.53
Faeth Therapeutics, Inc. (FTH)vs ›	$739.74M	0.00	0.09	0.09	0.07
AdaptHealth Corp. (AHCO)vs ›	$797.32M	1.50	1.31	1.32	1.45

NAME

MARKET CAP

DEBT TO EQUITY RATIO

TTM

Mesa Laboratories, Inc. (MLAB)

$767.66M

0.54

0.91

1.00

0.81

Attovia Therapeutics, Inc. (ATTO)vs ›

$774.97M

0.04

0.01

Lexicon Pharmaceuticals, Inc. (LXRX)vs ›

$775.17M

0.34

0.66

0.73

0.51

Design Therapeutics, Inc. (DSGN)vs ›

$758.23M

0.01

Sana Biotechnology, Inc. (SANA)vs ›

$782.00M

0.48

0.43

0.36

0.32

Apnimed, Inc. (APMD)vs ›

$788.50M

N/A

Gyre Therapeutics, Inc. (GYRE)vs ›

$793.58M

0.03

0.02

0.03

Geron Corporation (GERN)vs ›

$795.49M

0.56

0.77

0.65

0.53

Faeth Therapeutics, Inc. (FTH)vs ›

$739.74M

0.00

0.09

0.07

AdaptHealth Corp. (AHCO)vs ›

$797.32M

1.50

1.31

1.32

1.45

Debt to Equity Ratio FAQ

What is the debt to equity ratio for Mesa Laboratories, Inc. (MLAB)?

The debt to equity ratio for MLAB stock is 0.54.

Is Mesa Laboratories, Inc.'s debt to equity ratio high or low?

The debt to equity ratio of 0.54 is 34% below its 5-year average of 0.81, near the low end of its 5-year range (0.42–1.55).

What is the TTM average debt to equity ratio for Mesa Laboratories, Inc. (MLAB)?

The TTM average debt to equity ratio for MLAB stock is 0.91.

What is the 3Y average debt to equity ratio for Mesa Laboratories, Inc. (MLAB)?

The 3Y average debt to equity ratio for MLAB stock is 1.00.

What is the 5Y average debt to equity ratio for Mesa Laboratories, Inc. (MLAB)?

The 5Y average debt to equity ratio for MLAB stock is 0.81.

What is the 10Y average debt to equity ratio for Mesa Laboratories, Inc. (MLAB)?

The 10Y average debt to equity ratio for MLAB stock is 0.48.

What is the 15Y average debt to equity ratio for Mesa Laboratories, Inc. (MLAB)?

The 15Y average debt to equity ratio for MLAB stock is 0.40.

What is the 20Y average debt to equity ratio for Mesa Laboratories, Inc. (MLAB)?

The 20Y average debt to equity ratio for MLAB stock is 0.34.

DATE	DEBT TO EQUITY RATIO
2026-06-30	0.54
2026-03-31	0.83
2025-12-31	0.97
2025-09-30	1.07
2025-06-30	1.15
2025-03-31	1.14
2024-12-31	1.36
2024-09-30	1.38
2024-06-30	1.47
2024-03-31	1.55
2023-12-31	0.59
2023-09-30	0.45
2023-06-30	0.46
2023-03-31	0.47
2022-12-31	0.49
2022-09-30	0.53
2022-06-30	0.57
2022-03-31	0.56
2021-12-31	0.59
2021-09-30	0.42
2021-06-30	0.42
2021-03-31	0.36
2020-12-31	0.35
2020-09-30	0.37
2020-06-30	0.37
2020-03-31	0.64
2019-12-31	0.60
2019-09-30	0.60
2019-06-30	0.18
2019-03-31	0.20
2018-12-31	0.27
2018-09-30	0.31
2018-06-30	0.37
2018-03-31	0.47
2017-12-31	0.59
2017-09-30	0.49
2017-06-30	0.50
2017-03-31	0.56
2016-12-31	0.57
2016-09-30	0.58
2016-06-30	0.52
2016-03-31	0.53
2015-12-31	0.58
2015-09-30	0.59
2015-06-30	0.33
2015-03-31	0.36
2014-12-31	0.39
2014-09-30	0.37
2014-06-30	0.42
2014-03-31	0.26
2013-12-31	0.27
2013-09-30	0.00
2013-06-30	0.03
2013-03-31	0.08
2012-12-31	0.10
2012-09-30	0.17
2012-06-30	0.24
2012-03-31	0.00
2011-12-31	0.04
2011-09-30	0.10
2011-06-30	0.16
2011-03-31	0.18
2010-12-31	0.19
2010-09-30	0.13
2010-06-30	0.14
2010-03-31	0.00
2009-12-31	0.00
2009-09-30	0.00
2009-06-30	0.00
2009-03-31	0.00
2008-12-31	0.00
2008-09-30	0.00
2008-06-30	0.00
2008-03-31	0.00
2007-12-31	0.00
2007-09-30	0.00
2007-06-30	0.00
2007-03-31	0.00
2006-12-31	0.00
2006-09-30	0.00
2006-06-30	0.00
2006-03-31	0.00
2005-12-31	0.00
2005-09-30	0.00
2005-06-30	0.00
2005-03-31	0.00
2004-12-31	0.00
2004-09-30	0.00
2004-06-30	0.00
2004-03-31	0.00
2003-12-31	0.00
2003-09-30	0.00
2003-06-30	0.00
2003-03-31	0.00
2002-12-31	0.00
2002-09-30	0.00

DATE

DEBT TO EQUITY RATIO

2026-06-30

0.54

2026-03-31

0.83

2025-12-31

0.97

2025-09-30

1.07

2025-06-30

1.15

2025-03-31

1.14

2024-12-31

1.36

2024-09-30

1.38

2024-06-30

1.47

2024-03-31

1.55

2023-12-31

0.59

2023-09-30

0.45

2023-06-30

0.46

2023-03-31

0.47

2022-12-31

0.49

2022-09-30

0.53

2022-06-30

0.57

2022-03-31

0.56

2021-12-31

0.59

2021-09-30

0.42

2021-06-30

0.42

2021-03-31

0.36

2020-12-31

0.35

2020-09-30

0.37

2020-06-30

0.37

2020-03-31

0.64

2019-12-31

0.60

2019-09-30

0.60

2019-06-30

0.18

2019-03-31

0.20

2018-12-31

0.27

2018-09-30

0.31

2018-06-30

0.37

2018-03-31

0.47

2017-12-31

0.59

2017-09-30

0.49

2017-06-30

0.50

2017-03-31

0.56

2016-12-31

0.57

2016-09-30

0.58

2016-06-30

0.52

2016-03-31

0.53

2015-12-31

0.58

2015-09-30

0.59

2015-06-30

0.33

2015-03-31

0.36

2014-12-31

0.39

2014-09-30

0.37

2014-06-30

0.42

2014-03-31

0.26

2013-12-31

0.27

2013-09-30

0.00

2013-06-30

0.03

2013-03-31

0.08

2012-12-31

0.10

2012-09-30

0.17

2012-06-30

0.24

2012-03-31

0.00

2011-12-31

0.04

2011-09-30

0.10

2011-06-30

0.16

2011-03-31

0.18

2010-12-31

0.19

2010-09-30

0.13

2010-06-30

0.14

2010-03-31

0.00

2009-12-31

0.00

2009-09-30

0.00

2009-06-30

0.00

2009-03-31

0.00

2008-12-31

0.00

2008-09-30

0.00

2008-06-30

0.00

2008-03-31

0.00

2007-12-31

0.00

2007-09-30

0.00

2007-06-30

0.00

2007-03-31

0.00

2006-12-31

0.00

2006-09-30

0.00

2006-06-30

0.00

2006-03-31

0.00

2005-12-31

0.00

2005-09-30

0.00

2005-06-30

0.00

2005-03-31

0.00

2004-12-31

0.00

2004-09-30

0.00

2004-06-30

0.00

2004-03-31

0.00

2003-12-31

0.00

2003-09-30

0.00

2003-06-30

0.00

2003-03-31

0.00

2002-12-31

0.00

2002-09-30

0.00

Debt to Equity Ratio: 0.54

MLAB Debt to Equity Ratio

MLAB Average Debt to Equity Ratio Chart

MLAB Current vs Average Debt to Equity Ratio Chart

MLAB Debt to Equity Ratio Metrics

MLAB Competitors' Debt to Equity Ratio

Financial Health

Debt to Equity Ratio Formula & Definition

Debt to Equity Ratio FAQ

MLAB Debt to Equity Ratio History

Related Metrics